Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)
Status:
Terminated
Trial end date:
2009-06-11
Target enrollment:
Participant gender:
Summary
This study is proposed to evaluate the efficacy and safety of temozolomide, an oral
anti-cancer agent, in a participant population selected for a biomarker. Participants with
colorectal cancer, non-small-cell lung cancer, head and neck cancer, or esophageal cancer
will be included.